Sponsor Pipeline

Kissei Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
4
Recruiting
2
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
2
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07040137 Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration Spinocerebellar Degeneration Recruiting
NCT07015268 A Clinical Study of KLH-2109 in Patients With Endometriosis Endometriosis Active, Not Recruiting
Phase 2
NCT07604064 A Clinical Trial of Olutasidenib in Patients With Acute Myeloid Leukemia Relapsed or Refractory IDH1 Mutation-Positive Acute Myeloid Leukemia Recruiting
NCT06722729 A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease Parkinson Disease Active, Not Recruiting
Not specified
NCT06757257 Special Drug Use-results Survey for Long-term Use (Fostamatinib) Chronic Idiopathic Thrombocytopenic Purpura Recruiting
NCT06758271 Special Drug Use-results Survey for Long-term Use(Avacopan) Microscopic Polyangiitis (MPA) Recruiting
Disease Areas
Get alerts when Kissei Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free